These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37011024)

  • 1. Efficacy and Safety of 5-Fluorouracil Tattooing to Repigment Idiopathic Guttate Hypomelanosis: A Split-Body Randomized Trial.
    Arbache S; Hirata SH
    Dermatol Surg; 2023 Jun; 49(6):603-608. PubMed ID: 37011024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of melanocytes in idiopathic guttate hypomelanosis after 5-fluorouracil infusion using a tattoo machine: Preliminary analysis of a randomized, split-body, single blinded, placebo controlled clinical trial.
    Arbache S; Roth D; Steiner D; Breunig J; Michalany NS; Arbache ST; de Souza LG; Hirata SH
    J Am Acad Dermatol; 2018 Jan; 78(1):212-215. PubMed ID: 29241792
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on "Activation of melanocytes in idiopathic guttate hypomelanosis after 5-fluorouracil infusion using a tattoo machine: Preliminary analysis of a randomized, split-body, single blinded, placebo controlled clinical trial".
    Wambier CG
    J Am Acad Dermatol; 2018 Oct; 79(4):e79. PubMed ID: 29864463
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to: "Comment on 'Activation of melanocytes in idiopathic guttate hypomelanosis after 5-fluorouracil infusion using a tattoo machine: Preliminary analysis of a randomized, split-body, single blinded, placebo controlled clinical trial'".
    Arbache S; Michalany NS; Hirata SH
    J Am Acad Dermatol; 2018 Oct; 79(4):e81-e82. PubMed ID: 29864462
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-Fluorouracil tattooing for idiopathic guttate hypomelanosis.
    Wambier CG; Perillo de Farias Wambier S; Pereira Soares MT; Breunig J; Cappel MA; Landau M
    J Am Acad Dermatol; 2018 Apr; 78(4):e81-e82. PubMed ID: 29102493
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of tip cryotherapy in the treatment of idiopathic guttate hypomelanosis (IGH): a randomized, controlled, evaluator-blinded study.
    Laosakul K; Juntongjin P
    J Dermatolog Treat; 2017 May; 28(3):271-275. PubMed ID: 27494272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study.
    Gordon JR; Reed KE; Sebastian KR; Ahmed AM
    Dermatol Surg; 2017 Apr; 43(4):553-557. PubMed ID: 27930376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive understanding of idiopathic guttate hypomelanosis: clinical and histopathological correlation.
    Kim SK; Kim EH; Kang HY; Lee ES; Sohn S; Kim YC
    Int J Dermatol; 2010 Feb; 49(2):162-6. PubMed ID: 20465639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of idiopathic guttate hypomelanosis in 646 subjects and association with other aspects of photoaging.
    Shin MK; Jeong KH; Oh IH; Choe BK; Lee MH
    Int J Dermatol; 2011 Jul; 50(7):798-805. PubMed ID: 21699514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic guttate hypomelanosis-like lesions in patients with mycosis fungoides: a new adverse effect of phototherapy.
    Friedland R; David M; Feinmesser M; Fenig-Nakar S; Hodak E
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1026-30. PubMed ID: 20180893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic guttate hypomelanosis: idiopathic or ultraviolet induced?
    Kaya TI; Yazici AC; Tursen U; Ikizoglu G
    Photodermatol Photoimmunol Photomed; 2005 Oct; 21(5):270-1. PubMed ID: 16149941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of non-ablative fractional photothermolysis and 0.1% tacrolimus ointment is efficacious for treating idiopathic guttate hypomelanosis.
    Chitvanich S; Rerknimitr P; Panchaprateep R; Pongprutthipan M; Asawanonda P
    J Dermatolog Treat; 2016 Oct; 27(5):456-60. PubMed ID: 26864301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the pathogenesis of idiopathic guttate hypomelanosis.
    Falabella R; Escobar C; Giraldo N; Rovetto P; Gil J; Barona MI; Acosta F; Alzate A
    J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):35-44. PubMed ID: 3805391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of idiopathic guttate hypomelanosis with fractional carbon dioxide lasers.
    Goldust M; Mohebbipour A; Mirmohammadi R
    J Cosmet Laser Ther; 2013 May; ():. PubMed ID: 23656568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-ablative fractional photothermolysis in treatment of idiopathic guttate hypomelanosis.
    Rerknimitr P; Chitvanich S; Pongprutthipan M; Panchaprateep R; Asawanonda P
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2238-42. PubMed ID: 25303024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Numbers and differentiation status of melanocytes in idiopathic guttate hypomelanosis.
    Wallace ML; Grichnik JM; Prieto VG; Shea CR
    J Cutan Pathol; 1998 Aug; 25(7):375-9. PubMed ID: 9765023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical tacrolimus significantly promotes repigmentation in idiopathic guttate hypomelanosis: a double-blind, randomized, placebo-controlled study.
    Rerknimitr P; Disphanurat W; Achariyakul M
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):460-4. PubMed ID: 22324720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocyte abnormalities and senescence in the pathogenesis of idiopathic guttate hypomelanosis.
    Rani S; Kumar R; Kumarasinghe P; Bhardwaj S; Srivastava N; Madaan A; Parsad D
    Int J Dermatol; 2018 May; 57(5):559-565. PubMed ID: 29516488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypopigmented keratosis: is it a hyperkeratotic variant of idiopathic guttate hypomelanosis?
    Kim SK; Park JY; Hann SK; Kim YC; Lee ES; Kang HY
    Clin Exp Dermatol; 2013 Jul; 38(5):526-9. PubMed ID: 23600406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimecrolimus for idiopathic guttate hypomelanosis.
    Asawanonda P; Sutthipong T; Prejawai N
    J Drugs Dermatol; 2010 Mar; 9(3):238-9. PubMed ID: 20232585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.